Organization
Global Health Economics and Pricing
3 abstracts
Abstract
AN ECONOMIC EVALUATION ON THE USE OF TOCILIZUMAB (ROACTEMRA®) WITH METHOTREXATE IN THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS WHO HAVE FAILED TO RESPOND ADEQUATELY TO AN ANTI-TNF DRUG IN SCOTLAND Org: Healthcare Management, Roche Products Limited, Global Health Economics and Pricing, Genentech, THEMA Research Ltd,
Abstract
ASSESSING THE IMPACT OF ETANERCEPT TREATMENT ON PRODUCTIVITY: RESULTS FROM A RECENT RA PATIENT WORK LOSS AND PRODUCTIVITY SURVEYOrg: McKesson Specialty Health, McKesson Corporation, San Francisco Department of Public Health, Global Health Economics and Pricing, Amgen, Inc., Deerfield, United States of America,
Abstract
ASSESSING THE FREQUENCY WITH WHICH RHEUMATOID ARTHRITIS DISEASE ACTIVITY METRICS ARE RECORDED IN COMMUNITY-BASED RHEUMATOLOGY PRACTICES: RESULTS FROM A MEDICAL CHART REVIEWOrg: McKesson Specialty Health, McKesson Corporation, Global Health Economics and Pricing, Amgen, Inc., Deerfield, United States of America,